Consumer Reports warns that there are important considerations, especially for older adults, before starting these treatments.

Popular weight-loss therapies like Novo Nordisk's Wegovy and Eli Lilly's Zepbound result in both fat and muscle loss.

Weight-loss drugs have helped many people lose excess weight, but for some, rapid weight loss comes with a hidden risk—the loss of muscle and bone mass. This can increase the chances of developing osteoporosis, a condition that makes bones weak and more likely to break.

All doses of Novo's diabetes treatment Ozempic and weight-loss drug Wegovy were listed as available on the FDA's website in October, but the treatments were not taken off the offi

The shortage of Novo Nordisk’s (NVO) blockbuster diabetes and weight-loss drugs is officially over, according to the U.S. Food and Drug Administration (FDA).